P1006Patients with RBBB and concomitant delayed LV activation respond to CRT
Gianni Pastore(Ospedale Santa Maria della Misericordia di Rovigo), Loris Roncon(Ospedale Santa Maria della Misericordia di Rovigo), G. Corbucci, Michele Carraro, Massimiliano Maines(Center for Neuroscience and Cognitive Systems), Franco Noventa(University of Padua), C. Piccariello(Ospedale Santa Maria della Misericordia di Rovigo), Luca Conte(Ospedale Santa Maria della Misericordia di Rovigo), Enrico Baracca(Ospedale Santa Maria della Misericordia di Rovigo), Francesco Zanon(Ospedale Santa Maria della Misericordia di Rovigo), Lina Marcantoni(Ospedale Santa Maria della Misericordia di Rovigo)
Cited by 0
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
|Haematologica|2007|774
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
|New England Journal of Medicine|1992|685